Dürig J - Search Results

1

Publisher Correction: Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker.

Johansson P, Laguna T, Ossowski J, Pancaldi V, Brauser M, Dührsen U, Keuneke L, Queiros A, Richter J, Martín-Subero JI, Siebert R, Schlegelberger B, Küppers R, Dürig J, Penas EMM, Pau ECS, Bergmann AK. Johansson P, et al. Among authors: durig j. Clin Epigenetics. 2023 Jan 6;15(1):3. doi: 10.1186/s13148-022-01405-5. Clin Epigenetics. 2023. PMID: 36609404 Free PMC article. No abstract available.

2

Differential constitutive and activation-dependent expression of prion protein in human peripheral blood leucocytes.

Dürig J, Giese A, Schulz-Schaeffer W, Rosenthal C, Schmücker U, Bieschke J, Dührsen U, Kretzschmar HA. Dürig J, et al. Br J Haematol. 2000 Mar;108(3):488-95. doi: 10.1046/j.1365-2141.2000.01881.x. Br J Haematol. 2000. PMID: 10759704

3

Biological effects of stroma-derived factor-1 alpha on normal and CML CD34+ haemopoietic cells.

Dürig J, Rosenthal C, Elmaagacli A, Heyworth C, Halfmeyer K, Kasper C, Novotny J, Dührsen U. Dürig J, et al. Leukemia. 2000 Sep;14(9):1652-60. doi: 10.1038/sj.leu.2401875. Leukemia. 2000. PMID: 10995013

4

Differential expression of chemokine receptors in B cell malignancies.

Dürig J, Schmücker U, Dührsen U. Dürig J, et al. Leukemia. 2001 May;15(5):752-6. doi: 10.1038/sj.leu.2402107. Leukemia. 2001. PMID: 11368435

5

CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.

Dürig J, Naschar M, Schmücker U, Renzing-Köhler K, Hölter T, Hüttmann A, Dührsen U. Dürig J, et al. Leukemia. 2002 Jan;16(1):30-5. doi: 10.1038/sj.leu.2402339. Leukemia. 2002. PMID: 11840260

6

CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells.

Deaglio S, Capobianco A, Bergui L, Dürig J, Morabito F, Dührsen U, Malavasi F. Deaglio S, et al. Among authors: durig j. Blood. 2003 Sep 15;102(6):2146-55. doi: 10.1182/blood-2003-03-0989. Epub 2003 May 22. Blood. 2003. PMID: 12763926 Free article.

7

Salvage chemotherapy according to the ASHAP protocol: a single-center study of 24 patients with relapsed or refractory aggressive non-Hodgkin's lymphomas.

Nückel H, Dürig J, Dührsen U. Nückel H, et al. Among authors: durig j. Ann Hematol. 2003 Aug;82(8):481-486. doi: 10.1007/s00277-003-0678-1. Epub 2003 Jun 21. Ann Hematol. 2003. PMID: 12910375

8

ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia.

Dürig J, Nückel H, Cremer M, Führer A, Halfmeyer K, Fandrey J, Möröy T, Klein-Hitpass L, Dührsen U. Dürig J, et al. Leukemia. 2003 Dec;17(12):2426-34. doi: 10.1038/sj.leu.2403147. Leukemia. 2003. PMID: 14523469

9

1513A/C polymorphism in the P2X7 receptor gene in chronic lymphocytic leukemia: absence of correlation with clinical outcome.

Nückel H, Frey UH, Dürig J, Dührsen U, Siffert W. Nückel H, et al. Among authors: durig j. Eur J Haematol. 2004 Apr;72(4):259-63. doi: 10.1111/j.0902-4441.2003.00210.x. Eur J Haematol. 2004. PMID: 15089763

10

B-cell chronic lymphocytic leukemia with aberrant CD8 expression: genetic and immunophenotypic analysis of prognostic factors.

Schroers R, Pukrop T, Dürig J, Haase D, Dührsen U, Trümper L, Griesinger F. Schroers R, et al. Among authors: durig j. Leuk Lymphoma. 2004 Aug;45(8):1677-81. doi: 10.1080/10428190410001683697. Leuk Lymphoma. 2004. PMID: 15370224

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

243 results

Search Page

Filters